TrialBMC cancer2017

Phase I/II study of induction chemotherapy using carboplatin plus irinotecan and sequential thoracic radiotherapy (TRT) for elderly patients with limited-disease small-cell lung cancer (LD-SCLC): TORG 0604.

Yuki Misumi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.